Lu Lu
Impact in
- Infectious Diseases top 0.1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- Virology top 0.5%
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 103
- HIV/AIDS drug development and treatment 45
- Virology 69
- HIV Research and Treatment 66
- Co-authors
- Shi Jiang (176 shared papers)Shuai Xia (53 shared papers)Wei Xu (67 shared papers)Lanying Du (32 shared papers)Tianlei Ying (17 shared papers)Yun Zhu (27 shared papers)Qian Wang (56 shared papers)Qiaoshuai Lan (19 shared papers)
- Journals
- Viruses (16 papers)Emerging Microbes & Infections (13 papers)Microbes and Infection (12 papers)Signal Transduction and Targeted Therapy (11 papers)Journal of Virology (11 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Lu Lu
324 papers receiving 13.3k citations
Lu Lu's Hit Papers
Peers
Comparison fields: 5 of 156
- Infectious Diseases 7.9k
- Virology 1k
- Microbiology 292
- Biomaterials 453
- Immunology 590
Countries citing papers authored by Lu Lu
This map shows the geographic impact of Lu Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Lu more than expected).
Fields of papers citing papers by Lu Lu
This network shows the impact of papers produced by Lu Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Lu. The network helps show where Lu Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion Hit paper breakdown → | 2020 | 1091 |
| 2 | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody Hit paper breakdown → | 2020 | 989 |
| 3 | 2020 | 564 | |
| 4 | A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike Hit paper breakdown → | 2019 | 411 |
| 5 | AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells Hit paper breakdown → | 2021 | 394 |
| 6 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor Hit paper breakdown → | 2014 | 339 |
| 7 | Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients Hit paper breakdown → | 2021 | 323 |
| 8 | Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity Hit paper breakdown → | 2020 | 270 |
| 9 | 2020 | 247 | |
| 10 | 2016 | 233 | |
| 11 | 2020 | 226 | |
| 12 | 2020 | 224 | |
| 13 | 2014 | 207 | |
| 14 | 2020 | 173 | |
| 15 | 2020 | 168 | |
| 16 | 2013 | 158 | |
| 17 | 2022 | 149 | |
| 18 | 2022 | 141 | |
| 19 | 2018 | 138 | |
| 20 | 2020 | 131 |
About Lu Lu
Lu Lu is a scholar working on Infectious Diseases, Virology, Epidemiology, Oncology and Immunology, having authored 333 papers that have together received 13.6k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (103 papers), HIV Research and Treatment (66 papers), HIV/AIDS drug development and treatment (45 papers), Influenza Virus Research Studies (22 papers), Chemical Synthesis and Analysis (12 papers), Immunotherapy and Immune Responses (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Mosquito-borne diseases and control (8 papers). The work is most often cited by research in Infectious Diseases (7.9k citations), Virology (1k citations), Microbiology (292 citations), Biomaterials (453 citations) and Immunology (590 citations). Lu Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Shi Jiang, Shuai Xia, Wei Xu, Lanying Du, Tianlei Ying, Yun Zhu, Qian Wang, Qiaoshuai Lan, Yanling Wu and Shuwen Liu. Their work appears in journals such as Viruses, Emerging Microbes & Infections, Microbes and Infection, Signal Transduction and Targeted Therapy and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.